Komek, G; Schueller, J; Schaberl-Moser, R; Keil, F; Andel, J; Renner, F; Eisterer, W; Balcke, P; Scheithauer, W.
LIMITED TREATMENT DURATION & RE-INDUCTION OF THE SAME REGIMEN UPON PROGRESSION VERSUS TREATMENT UNTIL PROGRESSION WITH XELOX plus BEVACIZUMAB IN PATIENTS WITH ADVANCED COLORECTAL CANCER
ANN ONCOL. 2009; 20: 62-62.
[Poster]
Web of Science